Clonidine decreases plasma and cerebrospinal fluid arginine vasopressin but not oxytocin in humans.
To evaluate the alpha 2-noradrenergic regulation of arginine vasopressin (AVP) and oxytocin (OT) in normal humans, we measured the effect of the alpha 2-agonist clonidine on concentrations of these neuropeptides in both plasma and cerebrospinal fluid (CSF). Subjects underwent two lumbar puncture studies, one of which was performed 100 min after oral administration of 5 micrograms/kg clonidine. Plasma AVP and OT were measured at a single time point 10 min before lumbar puncture. Both plasma and CSF AVP were significantly lower in the clonidine condition than in the control (no drug) condition. Neither plasma nor CSF OT differed significantly between conditions. Our data confirm previous reports of alpha 2-noradrenergic inhibition of neurohypophyseal release of AVP into blood, and extend these findings to healthy human subjects. Our data also suggest that AVP appearance in CSF, presumably from extraneurohypophyseal vasopressinergic neurons, is regulated by an inhibitory alpha 2-noradrenergic mechanism.
Geriatric Research, Education and Clinical Center, Seattle, Wash.
E R
ER
Peskind
M A
MA
Raskind
R D
RD
Leake
M G
MG
Ervin
M G
MG
Ross
D M
DM
Dorsa
D000328:Adult; D001127:Arginine Vasopressin / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D003000:Clonidine / Q000494:pharmacology*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D008297:Male; D010121:Oxytocin / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*
D001127:Arginine Vasopressin; D010121:Oxytocin; D003000:Clonidine